Moderator: Edward J. Dohring, MD
1. Biomechanical and minimum one year clinical results of a novel 3D expandible cage for lumbar interbody fusion
Richard G. Fessler, MD, PhD1
1Rush University Medical Center, Dept of Neuro Surgery, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
2. Clinical outcomes following cervical and lumbar interbody fusion: The ENTRUST Clinical Study
Joseph O'Brien, MD, MPH1
1Washington Spine and Scoliosis Institute at OrthoBesthesda, Bethesda, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
3. A novel interbody fusion cage design: A Biomechanical and kinematic assessment of contact area, graft incorporation, and stability
Pierce D. Nunley, MD1; Lisa A. Ferrara, PhD, PhD2; Galyna Loughran, PhD3; Marcus Stone, PhD4
1Spine Institute of Louisiana, Shreveport, LA, US; 2Orthokinetic Technologies, LLC, Southport, NC, US; 3Excelen, Minneapolis, MN, US; 4Spine Institute of Louisiana Foundation, Shreveport, LA, US
FDA Device/Drug Status: Spineology Duo System (Approved for this indication)
4. BioAvailability of exosomes: In vitro and in vivo reciprocity?
Timothy Ganey, PhD1; Connie Chung, PhD2; Javorina Milosevic, PhD3; Shabnam M. Namin, PhD4; Renaud Sicard, PhD5; Hans Meisel, MD6
1Tampa, FL, US; 2Vivex Biomedical, Miami, FL, US; 3SpinPlant GmbH, Halle, Germany; 4Vivex Biologics, Inc., Miami, FL, US; 5Vivex, Biomedicals, Miami, FL, United States minor outlying islands; 6SpinPlant, Halle, Germany
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion, Questions & Answers
5. The use of augmented reality and a "virtual needle" for lumbar puncture
Ryan Parr1; Jacob Gibby, MD2
1American Fork, UT, US; 2Kaweah Delta Health Care District, Visalia, CA, US
FDA Device/Drug Status: FDA approval for preoperative surgical planning (Approved for this indication)
6. Gene expression indicating endochondral bone formation by viable bone allograft ViBone® in vivo
Abby Sukarto, PhD1; Frank Fan, PhD1; Dana Yoo, PhD2
1Richmond, CA, US; 2Silver Spring, MD, US
FDA Device/Drug Status: ViBone (Approved for this indication)
7. Use of machine-vision in spine surgery
Beau Standish1; Frank P. Cammisa, MD2; Tung T. Nguyen, MD3; Victor Yang, MD, PhD, FRCSC4
17D Surgical, Toronto, ON, Canada; 2The Hospital for Special Surgery, New York, NY, US; 3Neurosurgery at the Center for Bone and Joint Health, Nashua, NH, US; 4Div or Neurosurgery, University of Toronto/Div of Neuro, Sunnybrook Health Services Centre, Toronto, Canada
FDA Device/Drug Status: Machine-vision Image Guided Surgery (MvIGS) system (Approved for this indication)
8. Morphological and mechanical evaluation of newly formed bone following spinal fusion using a biomimetic peptide enhanced bone graft
Jacbus Arts, PhD1; Jeff G. Marx, PhD2; Scott Johnson3; Jerome Connor2; Bert van Rietbergen, PhD4
1Maastricht University Medical Centre , Maastricht, Netherlands; 2Cerapedics, Inc., Westminster, CO, US; 3CeraPedics, Inc., Westminster, CO, US; 4Eindhoven University of Technology, Eindhoven, Netherlands
FDA Device/Drug Status: I-FACTOR P15L Bone Graft (Investigational/Not approved)
Discussion, Questions & Answers